Skip to main content

Sectoral Advisory
Board

The Sectoral Advisory Board (SAB) is drawn from the health sector. They include individuals working in the private industry, and in large multinationals such as Novartis; regional companies such as Inqaba Biotech; agencies of the Ghana Government such as the Ghana Health Ministry; professional health organizations such as the African Society of Human Genetics; hospitals such as Korle Bu Teaching Hospital (KBTH); health policymakers, and advocacy groups such as the SCFG. The Sectoral Liaison Officer (Dr. Dei-Adomakoh) leading interactions with the SAB is a haematologist/oncologist in KBTH with working relationships with several companies that supply oncology drugs in the country, and are vested in the mission of WAGMC. There were consultations with several other stakeholders including MES-Equipment, a local supplier of biomedical research reagents that has engaged Agilent Technologies to partner with WAGMC. Besides advising the Centre in carrying out its mission, the SAB will play an active role in the management of the Centre with representations on the CMC.

Kwaku Ohene-Frempong

President, Sickle Cell Foundation of Ghana
Expertise: New Born Screening
Anticipated Contribution:

Provide strategic advice on all aspects of WAGMC, including education and training activities, and the regional development of genetic health professionals in West Africa.

Dennis Odai Laryea

Programme Manager, NCDs, Ghana Health Service
Expertise: Biomedical Science
Anticipated Contribution:

Provide strategic advice on how WAGMC can develop new short courses to meet the needs of the Ghana health service.

Philip Anderson

Head, Medical Affairs, Sub-Saharan Africa, Roche Pharmaceuticals
Expertise: Precision Medicine, Targeted Molecular Therapies
Anticipated Contribution:

To provide strategic advice on how WAGMC can access funds and in-kind support from the pharmaceutical industry to sustain the educational and research activities of the Centre.

Philip Ikeme

Head, Medical and Regulatory Affairs, Sanofi
Expertise: Precision Medicine, Targeted Molecular Therapies
Anticipated Contribution:

To provide strategic advice on how WAGMC can access funds and in-kind support from the pharmaceutical industry to sustain the educational and research activities of the Centre.

Peter Mensah

Sickle Cell Association of Ghana
Expertise: Law, Advocacy, Philanthropy
Anticipated Contribution:

As President of the Sickle cell association of Ghana, Mr. Mensah is well connected with all aspects of advocacy and philanthropy in Ghana. He will help the Centre network, and to get buy-in from patients into various Centre programs, particularly in community outreach.

Samuel Yaw Opoku

Registrar, Allied Health Professions Council

Benjamin Otchere

AGBL, Illumina